Global Neurovascular Devices Market - Forecasts from 2018 to 2023
Global neurovascular devices market is projected to witness a CAGR of 6.83% over the forecast period of 2017-2023. Neurovascular devices are used as an aid in the treatment of the various neurovascular disorders such as brain aneurysms, arteriovenous malformations (AVMs) and carotid artery disease. Growth in the market may be attributed to the upsurge in the number of patients suffering from neurovascular diseases and also rising preference of the minimally invasive devices owing to the quick healing time, less complications and short hospital Stays.
Rising Incidence of the Neurovascular Diseases to Augment the Market Growth
The increasing population coupled with the rising geriatric population at the risk of neurovascular diseases will boost the market for the neurovascular devices during the given time frame. As per the data by Center for Disease Control and Prevention (US), 7.4 million people suffered from stroke in US. Unhealthy lifestyle have increased the prevalence of the diseases such as hypertension, obesity, diabetes and high blood cholesterol which have further raised the chances of cerebrovascular disorders, thus, boosting the growth of the neurovascular devices market for the treatment of the disorders. Advancement in the field of the neurovascular disorder treatment such as the use of embolization for cerebral AVMs and internal carotid artery stenting for intracranial atherosclerotic disease will also bolster the market growth during the forecast period. However, the growth of the market might be restrained due to the high treatment cost and lack of trained professionals.
Asia Pacific to be lucrative market for Neurovascular Devices
Geographically, North America is estimated to hold the major share in the neurovascular devices market. The major factors driving the growth of the market in the region is the growing and quick adoption of the neurovascular devices coupled with the favourable reimbursement policies. Rising aware among the population regarding neurovascular devices will also boost the market in the region. Asia-Pacific will present a lucrative opportunity for the neurovascular devices owing to the rising patient base suffering from diseases such as stenosis, AVM, and strokes along with the improving healthcare infrastructure.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global neurovascular devices market.
Major industry players profiled as part of the report are Penumbra, Inc., Stryker and Phenox GmbH among others.
Segmentation
By Type
Neurovascular Access Devices
Angioplasty and Stenting Devices
Embolization Devices
Neurothrombectomy Devices
By Indication
Stroke
Arteriovenous Malformation (AVM)
Aneurysms
Stenosis
Others
By End-users
Hospitals
Ambulatory Surgical Centers
By Geography
North America
US
Canada
Others
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Others
Rising Incidence of the Neurovascular Diseases to Augment the Market Growth
The increasing population coupled with the rising geriatric population at the risk of neurovascular diseases will boost the market for the neurovascular devices during the given time frame. As per the data by Center for Disease Control and Prevention (US), 7.4 million people suffered from stroke in US. Unhealthy lifestyle have increased the prevalence of the diseases such as hypertension, obesity, diabetes and high blood cholesterol which have further raised the chances of cerebrovascular disorders, thus, boosting the growth of the neurovascular devices market for the treatment of the disorders. Advancement in the field of the neurovascular disorder treatment such as the use of embolization for cerebral AVMs and internal carotid artery stenting for intracranial atherosclerotic disease will also bolster the market growth during the forecast period. However, the growth of the market might be restrained due to the high treatment cost and lack of trained professionals.
Asia Pacific to be lucrative market for Neurovascular Devices
Geographically, North America is estimated to hold the major share in the neurovascular devices market. The major factors driving the growth of the market in the region is the growing and quick adoption of the neurovascular devices coupled with the favourable reimbursement policies. Rising aware among the population regarding neurovascular devices will also boost the market in the region. Asia-Pacific will present a lucrative opportunity for the neurovascular devices owing to the rising patient base suffering from diseases such as stenosis, AVM, and strokes along with the improving healthcare infrastructure.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global neurovascular devices market.
Major industry players profiled as part of the report are Penumbra, Inc., Stryker and Phenox GmbH among others.
Segmentation
By Type
Neurovascular Access Devices
Angioplasty and Stenting Devices
Embolization Devices
Neurothrombectomy Devices
By Indication
Stroke
Arteriovenous Malformation (AVM)
Aneurysms
Stenosis
Others
By End-users
Hospitals
Ambulatory Surgical Centers
By Geography
North America
US
Canada
Others
South America
Brazil
Argentina
Others
Europe
UK
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY TYPE
5.1. Neurovascular Access Devices
5.2. Angioplasty and Stenting Devices
5.3. Embolization Devices
5.4. Neurothrombectomy Devices
6. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY APPLICATION
6.1. Stroke
6.2. Arteriovenous Malformation (AVM)
6.3. Aneurysms
6.4. Stenosis
6.5. Others
7. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY END-USER
7.1. Hospitals
7.2. Ambulatory Surgical Centres
8. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Penumbra, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Development
10.2. MicroVention Inc.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Development
10.3. Stryker
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Development
10.4. Evasc Neurovascular Enterprises
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Development
10.5. Acandis GmbH
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Development
10.6. Memry Corporation
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Development
10.7. Phenox GmbH
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Development
10.8. Spartan Micro Inc.
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Development
10.9. Johnson & Johnson
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Development
10.10. Shape Memory Medical Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Development
List of Tables
List of Figures
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY TYPE
5.1. Neurovascular Access Devices
5.2. Angioplasty and Stenting Devices
5.3. Embolization Devices
5.4. Neurothrombectomy Devices
6. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY APPLICATION
6.1. Stroke
6.2. Arteriovenous Malformation (AVM)
6.3. Aneurysms
6.4. Stenosis
6.5. Others
7. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY END-USER
7.1. Hospitals
7.2. Ambulatory Surgical Centres
8. GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Penumbra, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Development
10.2. MicroVention Inc.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Development
10.3. Stryker
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Development
10.4. Evasc Neurovascular Enterprises
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Development
10.5. Acandis GmbH
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Development
10.6. Memry Corporation
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Development
10.7. Phenox GmbH
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Development
10.8. Spartan Micro Inc.
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Development
10.9. Johnson & Johnson
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Development
10.10. Shape Memory Medical Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Development
List of Tables
List of Figures
